Abstract
This chapter will review the use of biologic therapies other than infliximab for the treatment of Crohn disease and ulcerative colitis, with an emphasis on use in pediatric patients (Table 32.1). Included in the review will be information on the mechanisms of action for the various agents (Figure 32.1), efficacy and toxicity. When appropriate, data from clinical trials of these agents in children with dermatologic and rheumatologic disease will be included in order to give the reader the maximum information currently available on the use of these agents in children. © 2008 Springer Science+Business Media, LLC. All rights reserved.
Cite
CITATION STYLE
Tung, J., & Sandborn, W. J. (2008). Biologic therapies. In Pediatric Inflammatory Bowel Disease (pp. 403–427). Springer US. https://doi.org/10.1007/978-0-387-73481-1_32
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
